The TAIEX is undergoing a corrective period that is expected to persist for at least two more weeks, Financial Supervisory Commission (FSC) Chairwoman Jennifer Wang (王儷玲) said yesterday.
Wang’s comments came after the TAIEX shed 1 percent to close at 8,294.12 points, falling below the 26-week moving average, while foreign institutional investors sold a net NT$12.63 billion (US$39.22 million) worth of Taiwanese stocks.
Regarding heavy net selling by foreign institutional investors during yesterday’s session, Wang said that there are no concerns over capital flight from the local bourse.
She said that as of the end of last month, net foreign capital inflow to Taiwan tallied US$202.1 billion, of which US$1.75 billion was recorded last month.
“We have not detected a marked shift in net foreign capital inflow, although foreign institutions have been adjusting their investment allocation,” Wang said.
Wang said that apart from lingering global macroeconomic factors, the correction in the local bourse partly reflects uncertainties about the presidential handover on May 20.
She said that a majority of companies have indicated a positive outlook over the nation’s economic growth momentum in the second half, with most expecting a recovery from a trough in the first half.
In related news, credit card spending reached NT$199.6 billion in March to reach the fourth-highest level since tracking began in 2005, the commission said.
As of the end of March, Cathay United Bank (國泰世華銀行) was in the lead among credit card issuers, with spending reaching NT$33.54 billion in the month, followed by CTBC Bank Co Ltd (中國信託銀行) at NT$28.52 billion and E.Sun Commercial Bank (玉山銀行) at NT$22.43 billion.
The commission attributed the marked sequential jump to the lower number of business days in February, adding that more people have been paying recurring bills with credit cards.
However, revolving balance in the period dropped by NT$2 billion sequentially to NT$104.7 billion, commission data showed.
GlaxoSmithKline (GSK) in July made its consumer health products division a separate entity as it transforms into a world-leading biopharmaceutical company. By uniting science, technology and talent, the company is aiming to prevent and treat diseases with innovative vaccines, specialty pharmaceuticals and general medicines. GSK’s headquarters annually invests NT$192 billion (US$6.07 billion) in research and development, focusing on immune science and advanced technologies in human genetics. GSK’s drug and vaccine development focuses on infectious diseases, HIV, oncology and immunology. Investing in clinical trial research each year, GSK also brings drug development to Taiwan. It cooperates with 17 medical institutes and research
SLUMPING DEMAND: Inventory has climbed by up to 12 weeks as suppliers are under mounting pressure to offload excessive reserves, a TrendForce report said The price of DRAM chips is expected to fall at a steeper rate of 13 to 18 percent next quarter, as high inflation continues to weigh on demand for consumer electronics, causing chip inventories to soar, market researcher TrendForce Corp (集邦科技) said yesterday. The downtrend in DRAM prices could extend from a quarterly decline of 10 to 15 percent in the third quarter, the Taipei-based researcher said. “Demand for consumer electronics continued to stagnate during the third quarter, which used to be a high demand season,” TrendForce said in a statement. “During the quarter, memorychip consumption and shipments both showed quarterly
INEXPENSIVE POWER: Group chairman Gautam Adani said 70% of the investment would go into energy transition, with a focus on green hydrogen India’s Adani Group is to invest more than US$100 billion over the next decade, most of it in the energy transition business, chairman Gautam Adani said yesterday, as the ports-to-energy conglomerate accelerates an already aggressive expansion plan. After founding the group in 1988 as a commodities trading business, the 60-year-old has ventured into multiple sectors, mainly in the infrastructure space and in line with the priorities of the government of Indian Prime Minister Narendra Modi. “As a group, we will invest over US$100 billion of capital in the next decade,” Adani, the world’s second-richest person, told the Forbes Global CEO Conference in
Foxconn Technology Group (富士康科技集團) is to invest US$1.75 million in a joint venture with PT Indika Energy Tbk to explore commercial electric vehicle (EV) and electric battery business opportunities in Indonesia, the Taipei-based company said yesterday. With the investment, Foxconn would hold a 40 percent stake in the joint venture, PT Foxconn Indika Motor, while PT Indika would own 60 percent. The collaboration is an extension of a memorandum of understanding signed in January by Indika Energy, Foxconn, Gogoro Inc (睿能創意) and others aiming to build an electric vehicle supply chain in Southeast Asia’s biggest economy. Gogoro, in which Foxconn owns a 0.76